A critical breakthrough in cancer study is arising with the use of mini-antibodies to re-engage damaged p53. This crucial tumor inhibitor protein is frequently inactivated in several kinds of tumors, leading https://bookmarkassist.com/story21825259/vhh-fragments-revive-tumor-suppressor-p53-a-potential-approach-for-tumor-management